Administration (FDA), National Institutes of Health (NIH), World Health Organization (WHO), the
Journal of the American Medical Association (JAMA), and ex-Surgeon General C. Everett Koop had
found rbGH-treated milk to be indistinguishable from normal milk." Monsanto (manufacturer of rbGH)
Press Release, June, 1992" From 1984 to 1986, Dr. Daughaday was the recipient of a research contract
from Monsanto Co., a small fraction of which was paid to Dr. Daughaday as a consulting fee. JAMA, 264
(8), 8/22/90 (Dr. Daughaday, the author of the JAMA publication was an "independent authority" referred
to in Monsanto's Press Release)"Recombinant rbGH treatment produces an increase in the concentration
of insulin-like growth factor-I (IGF-I) in cow's milk." FDA review of genetically engineered milk
SCIENCE, 8/24/90, Vol 249 "After somidobove (rbGH) injection, mean IGF-I levels in the treated milk
are always higher than those found in the controls." World Health Organization Report Geneva,
Switzerland, June, 1992"Levels of IGF increase in milk after cows are treated with rbGH." December,
1990 National Institutes of Health Assessment of Bovine Somatotropin "A strong positive association was
observed between IGF-I levels and prostate cancer risk."Science, vol. 279. January 23, 1998
"Insulin-like growth factor (IGF)-I, a mitogenic and antiapoptotic peptide, can affect the proliferation of
breast epithelial cells, and is thought to have a role in breast cancer."The Lancet, vol. 351. May 9,
1998"Insulin-like growth factors (IGFs), in particular IGF-I and IGF-II, strongly stimulate the
proliferation of a variety of cancer cells, including those from lung cancer. High plasma levels of IGF-I
were associated with an increased risk of lung cancer. Plasma levels of IGF-I are higher...in patients with
lung cancer than in control subjects." Journal of the National Cancer Institute, vol. 91, no. 2. January 20,
1999. "Insulin-like growth factor-1 (IGF-1) is expressed in many tumor cell lines and has a role in both
normal cell proliferation and in the growth of cancers. Cancer Gene Ther., 2000 Mar, 7:3 "The insulin-
like growth factor (IGF) system is widely involved in human carcinogenesis. A significant association
between high circulating IGF-I concentrations and an increased risk of lung, colon, prostate and pre-
menopausal breast cancer has recently been reported. Lowering plasma IGF-I may thus represent an
attractive strategy to be pursued..." Int. J Cancer, 2000 Aug, 87:4, 601-5"... serum IGF-I levels increased
significantly in the milk drinking group, an increase of about 10% above baseline-but was unchanged in
the control group." Journal of the American Dietetic Association, vol. 99, no.10. October 1999A study
published in the Nov. 2004 issue of the American Journal of Clinical Nutrition. Further implicates whey
protein as a factor in postprandial insulin responses, which should caution diabetics about using milk
protein and whey in particular.
Whey Protein and Bone Loss
A study 28 comparing bone loss in the lumbar spine in perimenopausal woman showed that the control
group who supplemented the diet with whey protein, significant bone loss occurred. In the group who
supplemented the diet with isoflavone-rich soy protein, significant positive effect on bone mineral density
(BMD) and bone mineral content (BMC) occurred. The researchers at Iowa State University concluded
that regular consumption of isoflavone-rich soy protein could translate into a decrease in lifetime risk of
osteoporosis. By analogy, regular consumption of milk proteins such as whey could increase the lifetime
risk of osteoporosis.
Soy beats milk protein for cholesterol improvements: RCT
Supplements of soy protein, but not milk protein, may improve blood levels of HDL (good) cholesterol,
and enhance the overall cholesterol balance, says a new study 29.